Low-dose electron beam radiation and romidepsin therapy for symptomatic cutaneous T-cell lymphoma lesions

British Journal of Dermatology

Volumn 167, Issue 1, 2012, Pages 194-197

  Akilov, O E ^a   Grant, C ^b   Frye, R ^b   Bates, S ^b   Piekarz, R ^b   Geskin, Larisa ^b  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ROMIDEPSIN;

ADULT; ADVANCED CANCER; ARTICLE; CANCER RADIOTHERAPY; CANCER RELAPSE; CANCER STAGING; CLINICAL ARTICLE; CUTANEOUS T CELL LYMPHOMA; DRUG EFFICACY; ELECTRON THERAPY; FEMALE; HUMAN; LOW ENERGY RADIATION; MALE; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; RADIATION DOSE FRACTIONATION; RADIATION RESPONSE; SEZARY SYNDROME; TREATMENT RESPONSE;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; COMBINED MODALITY THERAPY; DEPSIPEPTIDES; FEMALE; HUMANS; LYMPHOMA, T-CELL, CUTANEOUS; MALE; MIDDLE AGED; RADIOTHERAPY DOSAGE; SKIN NEOPLASMS;

EID: 84863300616     PISSN: 00070963     EISSN: 13652133     Source Type: Journal    
DOI: 10.1111/j.1365-2133.2012.10905.x     Document Type: Article

References (15)

1. Dummer R, Assaf C, Bagot M et al. Maintenance therapy in cutaneous T-cell lymphoma: who, when, what? Eur J Cancer 2007; 43:2321-9. (Pubitemid 350001246)
2. Geskin LJ. Cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome). In: Williams Hematology (Kaushansky K, Lichtman MA, Beutler E, Kipps TJ, Seligsohn U, Prchal JT, eds). 8th edn. New York: McGraw-Hill, 2010; 1595-608.
3. NCCN. Clinical Practice Guidelines in Oncology: Non-Hodgkin's lymphomas (Zelenetz AD, Abramson JS, Advani RH et al., eds). vol. 1. Fort Washington, PA: National Comprehensive Cancer Network, Inc, 2012; 91-102.
4. Ueda H, Nakajima H, Hori Y et al. Action of FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum no. 968, on Ha-ras transformed NIH3T3 cells. Biosci Biotechnol Biochem 1994; 58:1579-83. (Pubitemid 2159869)
5. Piekarz RL, Frye R, Turner M et al. Phase II multi-institutional trial of the histone deacetylase inhibitor romidepsin as monotherapy for patients with cutaneous T-cell lymphoma. J Clin Oncol 2009; 27:5410-17.
6. Whittaker SJ, Demierre MF, Kim EJ et al. Final results from a multicenter, international, pivotal study of romidepsin in refractory cutaneous T-cell lymphoma. J Clin Oncol 2010; 28:4485-91.
7. Therasse P, Arbuck SG, Eisenhauer EA et al. New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada. J Natl Cancer Inst 2000; 92:205-16.
8. Cheson BD, Horning SJ, Coiffier B et al. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas NCI Sponsored International Working Group. J Clin Oncol 1999; 17:1244.
9. Zhang Y, Jung M, Dritschilo A et al. Enhancement of radiation sensitivity of human squamous carcinoma cells by histone deacetylase inhibitors. Radiat Res 2004; 161:667-74. (Pubitemid 39149575)
10. Kamstrup MR, Specht L, Skovgaard GL et al. A prospective, open-label study of low-dose total skin electron beam therapy in mycosis fungoides. Int J Radiat Oncol Biol Phys 2008; 71:1204-7.
11. Camphausen K, Tofilon PJ. Inhibition of histone deacetylation: a strategy for tumor radiosensitization. J Clin Oncol 2007; 25:4051-6. (Pubitemid 47492949)
12. Zhang Y, Adachi M, Zhao X et al. Histone deacetylase inhibitors FK228, N-(2-aminophenyl)-4-[N-(pyridin-3-yl-methoxycarbonyl) amino-methyl]benzamide and m-carboxycinnamic acid bis-hydroxamide augment radiation-induced cell death in gastrointestinal adenocarcinoma cells. Int J Cancer 2004; 110:301-8. (Pubitemid 38580407)
13. Cho HJ, Kim SY, Kim KH et al. The combination effect of sodium butyrate and 5-aza-2′-deoxycytidine on radiosensitivity in RKO colorectal cancer and MCF-7 breast cancer cell lines. World J Surg Oncol 2009; 7:49.
14. Sasakawa Y, Naoe Y, Inoue T et al. Effects of FK228, a novel histone deacetylase inhibitor, on human lymphoma U-937 cells in vitro and in vivo. Biochem Pharmacol 2002; 64:1079-90. (Pubitemid 35247815)
15. Palayoor ST, Macklis RM, Bump EA et al. Modulation of radiation-induced apoptosis and G2/M block in murine T-lymphoma cells. Radiat Res 1995; 141:235-43.